Skip to content
Open access

The AP5B1 p.Leu785Pro variant is a frequent cause of late-onset macular dystrophy with variable extraocular manifestations

Aug 2026 · HGG advances · Vol 7 · 0 citations · 31 references
Medicine

TL;DR

Findings further support AP5B1 as a cause of macular dystrophy, identify p.(Leu785Pro) as a relatively frequent pathogenic allele in individuals of European and Ashkenazi Jewish ancestry, and expand the associated phenotypic spectrum to include both isolated macular dystrophy and possible syndromic presentations.

Abstract

Summary Inherited retinal diseases (IRDs) represent a large group of genetically heterogeneous disorders that often cause progressive visual loss. The fifth adaptor protein (AP-5) complex, which contributes to endolysosomal trafficking and lysosomal homeostasis, has previously been implicated in neurodegenerative syndromes, and more recently, bi-allelic variants in three of its subunits were found in families with macular dystrophy, including four with variants in AP5B1. Here, we describe 22 affected individuals from 20 families with AP5B1-associated IRD, all carrying the recurrent missense variant c.2354T>C (GenBank: NM_138368.5) (p.Leu785Pro), either in the homozygous state (16 families) or in trans with another rare heterozygous AP5B1 missense or loss-of-function variant. Five families were of Ashkenazi Jewish ancestry and 15 families of European ancestry. Clinically, affected individuals presented with a predominantly late-onset macular dystrophy that frequently progressed to cone-rod degeneration. Characteristic retinal findings included foveal sparing, early peripapillary involvement, and a reticular pattern best observed by fundus autofluorescence imaging in the mid- or peripheral retina. The typical presenting symptom was decreased visual acuity. Age at onset ranged from 27 to 74 years, with most individuals becoming symptomatic after the fifth decade of life. Some individuals also presented with extraocular manifestations, most notably hearing loss, which was reported in 8 affected individuals. These findings further support AP5B1 as a cause of macular dystrophy, identify p.Leu785Pro as a relatively frequent pathogenic allele in individuals of European and Ashkenazi Jewish ancestry, and expand the associated phenotypic spectrum to include both isolated macular dystrophy and possible syndromic presentations.

Read PDF

Similar papers

Open access Aug 2026

SEPTIN9 R106W in a Chinese family with hereditary neuralgic amyotrophy: phenotypic heterogeneity and rehabilitation in a pediatric case

The broad clinical spectrum associated with the SEPTIN9 R106W mutation in a Chinese pedigree spanning from childhood to adulthood is delineated, highlighting the critical role of active inter vention in childhood-onset HNA.

Jing Chen, Shuang Chen, Xin-Yi Zhu et al. · 0 citations
Review Open access Aug 2026

KCNQ2 p.(Arg214Trp): systematic review with retrospective analysis and expanding the phenotype

A family with two adult carriers of the heterozygous KCNQ2 p.(Arg214Trp) variant is reported, identified through whole-exome sequencing, including long-term follow-up into late adulthood, challenging the concept of KCNQ2 p.(Arg214Trp) as a self-limited epilepsy-associated variant and indicating a broader phenotypic spectrum.

P. Christova, M. Ostrožovičová, J. Neupauerová et al. · 0 citations
Aug 2026

BHLHE22 monoallelic and biallelic variants cause a neurodevelopmental disorder with agenesis of the corpus callosum, intellectual disability, abnormal muscle tone and movement abnormalities.

The data establish BHLHE22 as a previously unrecognized neurodevelopmental disease gene that results in a distinct syndrome characterised by abnormalities in brain development, cognition, tone and movement.

Carolyn Le, T. Kalaycı, Z. Uyguner et al. · 0 citations
Case report Open access Aug 2026

A Novel SLC25A4 Variant Causing Mitochondrial Dysfunction, Myopathy and Cardiomyopathy: A Functional and Molecular Characterization

The molecular and functional spectrum of SLC25A4-associated disease is expanded and may inform clinical practice, including genetic interventions such as preimplantation genetic diagnosis, premarital genetic screening, targeted genetic counseling, and cascade testing of at-risk family members.

Mazhor Aldosary, Hanan Alqudairy, Nourah Alshalan et al. · 0 citations
Case report Aug 2026

A de novoNR2F1 c.330 C > A variant in Bosch-Boonstra-Schaaf optic atrophy syndrome presenting with early-onset developmental and epileptic encephalopathy

The novel NR2F1 variant was classified as likely pathogenic according to ACMG guidelines, confirming the diagnosis of BBSOAS and the ARF3 variant, identified as a secondary finding of uncertain clinical significance, is unlikely to account for the patient's phenotype.

Sina Babaei, Haneieh Honarmand, Mortaza Bonyadi et al. · 0 citations